Showing 36,902 results

Filters
New & experimental hepatitis C treatment

Polymerase Inhibitor PSI-7977 Works with Interferon or Companion Drug

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

First Sustained Response Data for Polymerase Inhibitor Mericitabine

Editor's pick
HIVandhepatitis.com
5 April 2011
Pharmaceutical industry

Medicines Patent Pool Launches Patent Information Resource to Aid People Working To Increase Access to HIV Medicines

Editor's pick
Medicines Patent Pool
4 April 2011
New & experimental hepatitis C treatment

Avalanche of hepatitis C products on the way

Editor's pick
Pharma Times
4 April 2011
Exposure to HIV through medical procedures

Libyan Father: We Lied about HIV Outbreak

Editor's pick
The Guardian
4 April 2011
Condoms & lubricant

Kenya: UN blames high rubber prices for condom shortage

Editor's pick
Business Daily
4 April 2011
Epidemiology & behaviour

Australia: A counter sexual revolution

Editor's pick
Hobart Mercury
4 April 2011
Ageing & HIV

Disparities: Illness More Prevalent Among Older Gay Adults

Editor's pick
New York Times
4 April 2011
Health services & systems

Africa turns to cellphones for better health

Editor's pick
The Independent
4 April 2011
Religion & faith

Report says people with HIV/Aids need more than prayers

Editor's pick
Independent Catholic News
4 April 2011
Finance & funding

Sanctions undermine Burma's AIDS prevention

Editor's pick
Radio Australia
4 April 2011
Condoms & lubricant

Thailand: Condoms to be given out at gay nightspots

Editor's pick
Bangkok Post
4 April 2011
New & experimental hepatitis C treatment

Bristol-Myers Interferon-Free Combo Cured Hepatitis Patients

Editor's pick
Bloomberg
4 April 2011
New & experimental hepatitis C treatment

Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France

Editor's pick
Bloomberg
4 April 2011
New & experimental hepatitis C treatment

Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011

Editor's pick
Business Wire
4 April 2011
New & experimental hepatitis C treatment

Inhibitex Reports Positive Safety and Antiviral Data from Its Phase 1b Study of HCV Nucleotide Inhibitor INX-189

Editor's pick
Pipeline Review
1 April 2011
New & experimental hepatitis C treatment

'Fantastic' data on Novartis' first-in-class hep C antiviral

Editor's pick
Pharma Times
1 April 2011
New & experimental hepatitis C treatment

Well-known statin could be recycled as HCV therapy supplement

Editor's pick
EASL
1 April 2011
Improving HIV care

Heineken announces three new projects focused on prevention and treatment of HIV/AIDS in Africa

Editor's pick
Heineken
1 April 2011
Migrants, refugees & displaced people

HIV positive victim of sex trafficking and rape faces imminent deportation from the UK

Editor's pick
Migrants' Rights Network
31 March 2011
Migrants, refugees & displaced people

UK: Social Services Support to People with No Recourse to Public Funds

Editor's pick
Migrants' Rights Network
31 March 2011
Hepatitis C treatment

EASL Clinical Practice Guidelines: Management of Hepatitis C Virus Infection

Editor's pick
EASL
31 March 2011
New & experimental hepatitis C treatment

Results From Phase 3 REALIZE Study Showed Telaprevir-Based Therapy Significantly Improved SVR (Viral Cure) Rates in People Whose Prior Treatment For Hepatitis C Was Unsuccessful

Editor's pick
Business Wire
31 March 2011
PrEP

PrEP: A Possible Approval Like No Other

Editor's pick
Poz
31 March 2011